Literature DB >> 21659414

Renin is an angiotensin-independent profibrotic mediator: role in pulmonary fibrosis.

E Montes1, V Ruiz, M Checa, V Maldonado, J Melendez-Zajgla, M Montaño, R Ordoñez-Razo, J Cisneros, C García-de-Alba, A Pardo, M Selman.   

Abstract

The pathogenesis of idiopathic pulmonary fibrosis (IPF) is probably the result of interplay between cytokines/chemokines and growth factors. The renin-angiotensin (Ang) system is involved, although its profibrotic effect is attributed to Ang II. However, recent studies suggest that renin, through a specific receptor, is implicated in fibrogenesis. In this study, the expression of renin and renin receptor was examined in normal and IPF lungs and fibroblasts. Normal human lung fibroblasts were stimulated with renin or transfected with renin small interfering RNA (siRNA), and the expression of transforming growth factor (TGF)-β1 and α-1-type I collagen was analysed. Normal lungs and lung fibroblasts expressed renin, which was strongly upregulated in IPF lungs and fibroblasts (∼10-fold increase; p<0.05). Immunocytochemistry showed intense renin staining in IPF fibroblasts. Renin-stimulated lung fibroblasts displayed an increase in the expression of TGF-β1 (mean ± sd 1.8 × 10(3) ± 0.2 × 10(3) versus 1.2 × 10(3)± 0.3 × 10(3) mRNA copies per 18S ribosomal RNA; p<0.01) and collagen (5.93 × 10(2)± 0.66 × 10(2) versus 3.28 × 10(2) ± 0.5 × 10(2); p<0.01), while knocking down renin expression using siRNA provoked a strong decrease of both molecules. These effects were independent of Ang II, since neither losartan nor captopril decreased these effects. Renin also decreased matrix metalloprotease-1 expression and induced TGF-β1 activation (163 ± 34 versus 110 ± 15 pg active TGF-β1 per mg total protein). These findings highlight the possible role of renin as an Ang II-independent profibrotic factor in lung fibrosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21659414     DOI: 10.1183/09031936.00130310

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  14 in total

Review 1.  Cardiac fibrosis: potential therapeutic targets.

Authors:  Shuin Park; Ngoc B Nguyen; Arash Pezhouman; Reza Ardehali
Journal:  Transl Res       Date:  2019-03-09       Impact factor: 7.012

2.  Evaluation of Renin and Soluble (Pro)renin Receptor in Patients with IPF. A Comparison with Hypersensitivity Pneumonitis.

Authors:  Montes Eduardo; Buendía-Roldan Ivette; Díaz-Piña Gabriela; Moreno-Avila Veronica; Ruiz Victor
Journal:  Lung       Date:  2019-10-15       Impact factor: 2.584

3.  Angiotensin Receptor Blockers and Subclinical Interstitial Lung Disease: The MESA Study.

Authors:  Whitney D Gannon; Michaela R Anderson; Anna J Podolanczuk; Steven M Kawut; Erin D Michos; Vincent Cottin; Michael Kreuter; Ganesh Raghu; R Graham Barr; David J Lederer
Journal:  Ann Am Thorac Soc       Date:  2019-11

4.  Aliskiren attenuates bleomycin-induced pulmonary fibrosis in rats: focus on oxidative stress, advanced glycation end products, and matrix metalloproteinase-9.

Authors:  Sally A Abuelezz; Nevien Hendawy; Wesam M Osman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-05-07       Impact factor: 3.000

5.  Profibrosing effect of angiotensin converting enzyme inhibitors in human lung fibroblasts.

Authors:  Gabriela Díaz-Piña; Eduardo Montes; Marco Checa; Carina Becerril; Carolina García de Alba; Anita Vega; Ignacio Páramo; Rosa Ordoñez-Razo; Victor Ruiz
Journal:  Lung       Date:  2015-02-06       Impact factor: 2.584

6.  A review of current and novel therapies for idiopathic pulmonary fibrosis.

Authors:  Rokhsara Rafii; Maya M Juarez; Timothy E Albertson; Andrew L Chan
Journal:  J Thorac Dis       Date:  2013-02       Impact factor: 2.895

7.  Assessment of Alamandine in Pulmonary Fibrosis and Respiratory Mechanics in Rodents.

Authors:  Renata Streck Fernandes; Henrique Bregolin Dias; Wynnie Amaral de Souza Jaques; Tiago Becker; Katya Rigatto
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2021-05-18       Impact factor: 1.636

8.  Tanshinone IIA attenuates bleomycin-induced pulmonary fibrosis via modulating angiotensin-converting enzyme 2/ angiotensin-(1-7) axis in rats.

Authors:  Huajie Wu; Yan Li; Yanxia Wang; Dunquan Xu; Congcong Li; Manling Liu; Xin Sun; Zhichao Li
Journal:  Int J Med Sci       Date:  2014-04-07       Impact factor: 3.738

9.  Chronic Activation of the Renin-Angiotensin System Induces Lung Fibrosis.

Authors:  Jiaolong Wang; Li Chen; Bohao Chen; Angelo Meliton; Shu Q Liu; Yongyan Shi; Tianjing Liu; Dilip K Deb; Julian Solway; Yan Chun Li
Journal:  Sci Rep       Date:  2015-10-23       Impact factor: 4.379

10.  Effects of direct Renin inhibition on myocardial fibrosis and cardiac fibroblast function.

Authors:  Hui Zhi; Ivan Luptak; Gaurav Alreja; Jianru Shi; Jian Guan; Nicole Metes-Kosik; Jacob Joseph
Journal:  PLoS One       Date:  2013-12-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.